Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study

Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study

Objectives Spontaneous pneumomediastinum (SPNM) historically has been considered a poor prognostic factor in dermatomyositis/polymyositis patients complicated with interstitial lung disease (ILD). However, there is a lack of actual data regarding the association between SPNM occurrence and mortality...

Full description

Bibliographic Details
Main Authors:	Kei Ikeda, Taro Iwamoto, Shunsuke Furuta, Takao Sugiyama, Hiroshi Nakajima, Shin-ichiro Kagami, Yoshihisa Kobayashi, Daiki Nakagomi, Kazuya Abe
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-03-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/9/1/e002770.full

Similar Items

Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
by: Chiara Scirocco, et al.
Published: (2020-01-01)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)

HRCT Features of Dermatomyositis-/Polymyositis- Associated Interstitial Lung Disease
by: Zhenzhong MA, et al.
Published: (2024-07-01)

Research progress in the treatment of interstitial lung disease related to polymyositis/dermatomyositis
by: ZHENG Xiaofeng, et al.
Published: (2024-04-01)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
by: Stefano Palmucci, et al.
Published: (2022-11-01)

Risk of cancer in dermatomyositis or polymyositis.
by: Hilton-Jones, D, et al.
Published: (1992)

Spontaneous pneumomediastinum in dermatomyositis
by: Ankit Jain, et al.
Published: (2017-01-01)

KL-6 in adult polymyositis and dermatomyositis patients and its correlation with interstitial lung disease
by: Mayada Khalil, et al.
Published: (2023-12-01)

Respiratory disorders in patients with polymyositis/dermatomyositis
by: Olga Alekseyevna Antelava, et al.
Published: (2014-03-01)

Polymyositis and dermatomyositis: Disease spectrum and classification
by: Siba P Raychaudhuri, et al.
Published: (2012-01-01)

Pneumomediastinum and pneumorrhachis as complications of dermatomyositis
by: Tatiana Almeida Gonçalves, et al.
Published: (2021-12-01)

Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease
by: Min Yu, et al.
Published: (2024-05-01)

Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan
by: Qingqing Hu, et al.
Published: (2023-10-01)

Combination therapy with methylprednisolone, rituximab, and tofacitinib in antimelanoma differentiation‐associated 5 gene dermatomyositis with rapidly progressive interstitial lung disease
by: Mona Manghani, et al.
Published: (2024-06-01)

Development of comorbid infection in patients with polymyositis/dermatomyositis
by: O A Antelava, et al.
Published: (2009-06-01)

Clinical types of lung disease in polymyositis and dermatomyositis
by: Inna B. Bondarenko, et al.
Published: (2021-04-01)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.
by: Agnieszka Trybuch, et al.
Published: (2023-07-01)

Polymyositis-Dermatomyositis and Interstitial Lung Disease in Pregnant Woman Successfully Treated with Cyclosporine and Tapered Steroid Therapy
by: Saito Mayu, et al.
Published: (2019-01-01)

HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.
by: Xiaoming Shu, et al.
Published: (2016-01-01)

Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
by: Li Zhang, et al.
Published: (2016-01-01)

Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation
by: Hui Li, et al.
Published: (2025-02-01)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
by: Kei Ikeda, et al.
Published: (2023-03-01)

The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study
by: Chong Hong Lim, et al.
Published: (2018-06-01)

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
by: Chester V. Oddis, et al.
Published: (2022-11-01)

Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis
by: Zoltan Griger, et al.
Published: (2020-09-01)

Refractory antimelanoma differentiation-associated gene 5 antibody negative ulcerative dermatomyositis responsive to mycophenolate mofetil
by: Sumeyye Ozer, MD, et al.
Published: (2024-08-01)

A Case of Amyopathic Dermatomyositis with Pneumomediastinum and Subcutaneous Emphysema
by: Aslıhan Gürün Kaya, et al.
Published: (2015-01-01)

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
by: Shimojima Yasuhiro, et al.
Published: (2012-11-01)

ANTISYNTHETASE SYNDROME IS THE MOST SEVERE SUBTYPE OF POLYMYOSITIS/DERMATOMYOSITIS:DESCRIPTION OF CASES
by: Olga Alekseyevna Antelava, et al.
Published: (2009-12-01)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
by: mei liu, et al.
Published: (2023-11-01)

Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
by: Victoria Psomiadou, et al.
Published: (2021-01-01)

Inflammatory Bowel Diseases Are Associated with Polymyositis and Dermatomyositis—A Retrospective Cohort Analysis
by: Kassem Sharif, et al.
Published: (2022-11-01)

Malignancy in a retrospective cohort of 17 patients with Dermatomyositis or Polymyositis in southern Tunisia
by: Sellami Khadija, et al.
Published: (2018-12-01)

A bibliometric analysis of the research status and trends in studies on polymyositis and dermatomyositis with interstitial lung disease from 2000 to 2022 using Web of Science
by: Xiao‐Na Ma, et al.
Published: (2024-02-01)

Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
by: Hironao Hozumi, et al.
Published: (2015-01-01)

Serum progranulin level is a novel tool for monitoring disease activity of dermatomyositis with antimelanoma differentiation‐associated protein 5 antibodies
by: Asami Fujii, et al.
Published: (2021-06-01)

Prevalence of hearing loss, tinnitus, vertigo and sudden deafness among patients with polymyositis and dermatomyositis
by: Shih-Han Hung, et al.
Published: (2024-03-01)

Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach
by: Ha-Neul Jeong, et al.
Published: (2023-12-01)

T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis
by: Yasuhiro Shimojima, et al.
Published: (2017-11-01)

Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
by: Levine T
Published: (2012-06-01)